Physician profile
Jay A Epstein
NPI 1619013604
$654.25
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $33.80 · 2021: $38.91 · 2022: $245.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $245.28 | 2022 | |
| Abbvie INC. | $216.38 | 2019 | |
| Alexion Pharmaceuticals, INC. | $106.32 | 2019 | |
| Daiichi Sankyo INC. | $21.03 | 2021 | |
| Millicent US INC | $18.57 | 2020 | |
| Mayne Pharma Commercial LLC | $17.88 | 2021 | |
| Therapeuticsmd, INC. | $15.23 | 2020 | |
| Amag Pharmaceuticals, INC. | $13.56 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Epstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.